Bicycle Therapeutics PLC SEC filings BCYC

Bicycle Therapeutics PLC has 660 filings in SEC EDGAR's recent list, going back to Dec 21, 2018. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Bicycle Therapeutics PLC SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 29, 2026 Oct 29, 2026
4/A Filing Oct 7, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
4 Insider transaction Oct 6, 2026 Oct 2, 2026
3/A Filing Oct 6, 2026 Jun 22, 2023
144 Notice of proposed sale Oct 2, 2026 —
8-K Current report
Officer or director change
Aug 20, 2026 Aug 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 30, 2026 Jul 30, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
4 Insider transaction Jul 7, 2026 Jul 2, 2026
144 Notice of proposed sale Jul 2, 2026 —
8-K Current report
Shareholder vote results
Jun 18, 2026 Jun 17, 2026
8-K Current report
Other events
May 21, 2026 May 21, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 4, 2026 —
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 30, 2026 Apr 30, 2026
ARS Annual report to shareholders Apr 22, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 22, 2026 Jun 17, 2026
8-K Current report
Other events
Apr 20, 2026 Apr 20, 2026
4 Insider transaction Apr 6, 2026 Apr 2, 2026
4 Insider transaction Apr 6, 2026 Apr 2, 2026
4 Insider transaction Apr 6, 2026 Apr 2, 2026
4 Insider transaction Apr 6, 2026 Apr 2, 2026
4 Insider transaction Apr 6, 2026 Apr 2, 2026
PRE 14A Preliminary proxy statement Apr 3, 2026 Jun 17, 2026
144 Notice of proposed sale Apr 2, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
144 Notice of proposed sale Apr 2, 2026 —
3 Initial insider ownership Mar 25, 2026 Mar 17, 2026
S-8 Employee stock plan registration Mar 17, 2026 —
10-K Annual report Mar 17, 2026 Dec 31, 2025
8-K Current report
Results of operations, Officer or director change
Mar 17, 2026 Mar 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 4, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Mar 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 3, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 11, 2026 —
4 Insider transaction Feb 4, 2026 Feb 3, 2026
8-K Current report
Officer or director change
Feb 3, 2026 Jan 29, 2026
8-K Current report
Other events
Jan 12, 2026 Jan 12, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
144 Notice of proposed sale Jan 5, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
S-8 Employee stock plan registration Oct 30, 2025 —
10-Q Quarterly report Oct 30, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 30, 2025 Oct 30, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 6, 2025 Oct 2, 2025
144 Notice of proposed sale Oct 2, 2025 —
144 Notice of proposed sale Oct 2, 2025 —
144 Notice of proposed sale Oct 2, 2025 —
144 Notice of proposed sale Oct 2, 2025 —
144 Notice of proposed sale Oct 2, 2025 —
144 Notice of proposed sale Oct 2, 2025 —
4 Insider transaction Sep 10, 2025 Sep 8, 2025
4 Insider transaction Sep 10, 2025 Sep 8, 2025
3 Initial insider ownership Sep 10, 2025 Sep 8, 2025
3 Initial insider ownership Sep 10, 2025 Sep 8, 2025
8-K Current report
Officer or director change
Sep 8, 2025 Sep 8, 2025
EFFECT Filing Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Aug 14, 2025 Aug 12, 2025
3 Initial insider ownership Aug 14, 2025 Aug 12, 2025
424B3 Prospectus Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
CORRESP Letter to the SEC Aug 12, 2025 —
UPLOAD Letter from the SEC Aug 12, 2025 —
S-3 Shelf registration Aug 8, 2025 —
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Results of operations, Officer or director change
Aug 8, 2025 Aug 6, 2025
4 Insider transaction Jul 7, 2025 Jul 2, 2025
4 Insider transaction Jul 7, 2025 Jul 2, 2025
4 Insider transaction Jul 7, 2025 Jul 2, 2025
4 Insider transaction Jul 7, 2025 Jul 2, 2025
4 Insider transaction Jul 7, 2025 Jul 2, 2025
4 Insider transaction Jul 7, 2025 Jul 2, 2025
144 Notice of proposed sale Jul 2, 2025 —
144 Notice of proposed sale Jul 2, 2025 —
144 Notice of proposed sale Jul 2, 2025 —
144 Notice of proposed sale Jul 2, 2025 —
144 Notice of proposed sale Jul 2, 2025 —
144 Notice of proposed sale Jul 2, 2025 —
8-K Current report
Shareholder vote results
Jun 17, 2025 Jun 17, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
8-K Current report
Regulation FD disclosure
Apr 29, 2025 Apr 29, 2025
ARS Annual report to shareholders Apr 23, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 23, 2025 Jun 17, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
PRE 14A Preliminary proxy statement Apr 4, 2025 Jun 17, 2025
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
144 Notice of proposed sale Apr 2, 2025 —
4 Insider transaction Mar 27, 2025 Mar 25, 2025
3 Initial insider ownership Mar 27, 2025 Mar 25, 2025
4 Insider transaction Mar 27, 2025 Mar 25, 2025
3 Initial insider ownership Mar 27, 2025 Mar 25, 2025
8-K Current report
Officer or director change, Other events
Mar 27, 2025 Mar 21, 2025
8-K Current report Mar 14, 2025 Mar 12, 2025
S-8 Employee stock plan registration Feb 25, 2025 —
10-K Annual report Feb 25, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 25, 2025 Feb 25, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 11, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
144 Notice of proposed sale Jan 6, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Dec 20, 2024 —
SCHEDULE 13G Ownership over 5% (passive) Dec 19, 2024 —
SC 13D/A Amended ownership over 5% (active) Dec 17, 2024 —
4 Insider transaction Dec 17, 2024 Dec 13, 2024
8-K Current report
Other events
Dec 13, 2024 Dec 13, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
4 Insider transaction Nov 13, 2024 Nov 11, 2024
144 Notice of proposed sale Nov 12, 2024 —
10-Q Quarterly report Oct 31, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 31, 2024 Oct 31, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BCYC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
United Kingdom
Headquarters
Cambridge, United Kingdom
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1761612
Former names
BICYCLE THERAPEUTICS Ltd (until May 24, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.